1-20 of 1571
Image
Postacne atrophic scars. (a) Before and (b) after 12 months of treatment wi...
Published: 23 April 2025
Figure 2
Postacne atrophic scars. (a) Before and (b) after 12 months of treatment with topical insulin a good response was observed.
Image
Postacne atrophic scars. (a) Before and (b) after 12 months of treatment wi...
Published: 23 April 2025
Figure 3
Postacne atrophic scars. (a) Before and (b) after 12 months of treatment with topical insulin, a moderate response was observed.
Image
Postoperative atrophic scars. (a) Before and (b) after 12 months of treatme...
Published: 23 April 2025
Figure 7
Postoperative atrophic scars. (a) Before and (b) after 12 months of treatment, a good response was observed.
Image
Impact of atrophic scars on daily life. (a) Before and (b) after 12 months ...
Published: 23 April 2025
Figure 8
Impact of atrophic scars on daily life. (a) Before and (b) after 12 months of treatment with topical insulin.
Journal Article
Efficacy and safety of microneedling with topical insulin compared with placebo in the treatment of atrophic scars: a prospective study and literature review
Skin Health and Disease, vzaf032, https://doi.org/10.1093/skinhd/vzaf032
Published: 23 April 2025
Image
Postleishmaniasis atrophic scars. (a) Before and (b) after 12 months of tre...
Published: 23 April 2025
Figure 4
Postleishmaniasis atrophic scars. (a) Before and (b) after 12 months of treatment with topical insulin, a good response was observed.
Image
Postleishmaniasis atrophic scars. (a) Before and (b) after 12 months of tre...
Published: 23 April 2025
Figure 5
Postleishmaniasis atrophic scars. (a) Before and (b) after 12 months of treatment with topical insulin, a good response was observed.
Image
Postleishmaniasis atrophic scars. (a) Before and (b) after 12 months of tre...
Published: 23 April 2025
Figure 6
Postleishmaniasis atrophic scars. (a) Before and (b) after 12 months of treatment with topical insulin, a good response was observed.
Journal Article
Skin cancer screening practices of UK hairdressers and barbers for their customers: a preliminary study
Skin Health and Disease, vzaf015, https://doi.org/10.1093/skinhd/vzaf015
Published: 22 April 2025
Image
Number of participants screening and advising customers who know someone wh...
Published: 22 April 2025
Figure 1
Number of participants screening and advising customers who know someone who has had skin cancer. a The bar chart shows that 89% of participants screening customers knew someone who had been diagnosed with skin cancer [χ 2 = 5.40, degrees of freedom (df) = 1, P < 0.02], and 85% of those advis
Image
(a) Nontender subcutaneous nodules in the left arm. No significant changes ...
Published: 22 April 2025
Figure 1
(a) Nontender subcutaneous nodules in the left arm. No significant changes in the epidermis were observed. (b, c) Radiography revealed extensive subcutaneous nodules (arrowhead) in the extremities. (b) Left arm. (c) Lower limb. (d) High-frequency ultrasonography showed hypoechogenic masses with post
Journal Article
Oral and topical vitamin D treatment strategies in psoriasis
Skin Health and Disease, vzaf010, https://doi.org/10.1093/skinhd/vzaf010
Published: 22 April 2025
Journal Article
Trisomy 18 with widespread calcinosis cutis
Skin Health and Disease, vzaf023, https://doi.org/10.1093/skinhd/vzaf023
Published: 22 April 2025
Journal Article
Investigating the potential of oncolytic viruses in the treatment of melanoma: where do we go from here?
Skin Health and Disease, vzaf022, https://doi.org/10.1093/skinhd/vzaf022
Published: 22 April 2025
Image
Mechanism of action for vitamin D in psoriasis. 7DHC, 7-dehydrocholesterol;...
Published: 22 April 2025
Figure 1
Mechanism of action for vitamin D in psoriasis. 7DHC, 7-dehydrocholesterol; IL-17, interleukin 17; pDC, plasmacytoid dendritic cell; Th1, T helper 1; Th17, T helper 17; TNFa, tumor necrosis factor-alpha; UVB, ultraviolet B.
Image
Comparison of the screening of customers by hairdressers and barbers, advis...
Published: 22 April 2025
Figure 2
Comparison of the screening of customers by hairdressers and barbers, advising customers and those who had advised customers whose customers had gone on to receive a diagnosis of skin cancer. a A statistically significant difference was observed between the groups for those who had had a customer d
Image
Data management in DREAM TO TREAT AD.
Published: 22 April 2025
Figure 1
Data management in DREAM TO TREAT AD.
Image
Data harmonization, data flow and analysis in the DREAM TO TREAT AD (D2T AD...
Published: 22 April 2025
Figure 2
Data harmonization, data flow and analysis in the DREAM TO TREAT AD (D2T AD) study. TREAT RT, TREAT Registry Taskforce.
Image
The main administration routes used to deliver oncolytic viruses (OVs) in p...
Published: 22 April 2025
Figure 1
The main administration routes used to deliver oncolytic viruses (OVs) in patients: (i) intratumoral delivery whereby the OV is injected directly into the tumour; (ii) intravenous delivery, which entails administration of the OV via the veins; (iii) intraperitoneal delivery, which involves administe
